Imunon, Inc.
IMNNOther · Non-accelerated filer<br>Smaller reporting company · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $500,000 | $500,000 | $500,000 |
| Operating income | −$14.7M | −$19.1M | −$21.0M | −$24.9M | −$21.0M | −$18.5M |
| Net income | −$14.5M | −$18.6M | −$19.5M | −$35.9M | −$20.8M | −$21.5M |
| Total assets | $12.3M | $9.7M | $21.9M | $44.0M | $74.0M | $37.5M |
| Total liabilities | $5.2M | $5.5M | $8.5M | $14.6M | $18.3M | $18.9M |
| Equity | $7.1M | $4.2M | $13.4M | $29.3M | $55.8M | $18.6M |
| EPS (diluted) | $-6.83 | $-16.94 | $-2.16 | $-5.03 | $-3.83 | — |
| Shares out. | 14.6M | 9.4M | 9.1M | 5.8M | 75.0M | 29.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −205.3%
- Return on assets
- −118.0%
- Return on capital (ROCE)
- −191.2%
- Liabilities / assets
- 42.5%
- Debt / equity
- 0.74×
- Book value / share
- $0.48
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -115.11distress
- Accruals / assets
- −4.9%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Tardugno Michael HOfficer — Executive Chairman of Board | May 22, 2026 | Grant | 3,484 | $2.20 |
| Pellizzari Christine ADirector | May 22, 2026 | Grant | 5,557 | $2.20 |
| Dentzer James EDirector | May 22, 2026 | Grant | 11,148 | $2.20 |
| Braun Donald PDirector | May 22, 2026 | Grant | 5,011 | $2.20 |
| Fritz Frederick J.Director | May 22, 2026 | Grant | 10,330 | $2.20 |
| Lindborg StacyOfficer — President and CEO | May 22, 2026 | Grant | 1,491 | $2.20 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 146,860 | 3.6 | -6.0% |
| Apr 30, 2026 | 156,240 | 5.5 | +9.8% |
| Apr 15, 2026 | 142,264 | 4.2 | -23.9% |
| Mar 31, 2026 | 186,889 | 1.0 | -10.5% |
| Mar 13, 2026 | 208,865 | 12.5 | -2.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 12, 2026
- Director / officer changeMay 4, 2026
- Results of operationsMar 31, 2026
- Other material eventMar 23, 2026
- Director / officer changeFeb 5, 2026
- Director / officer changeJan 7, 2026
- Entered a material agreement · Other material eventDec 31, 2025
- Results of operationsNov 13, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.